Veranex, backed by Summit Partners, Accelmed and Laurexa Capital Partners, has acquired Orange, California-based Fusion Biotec.
The combination of Veranex’s infrastructure and experience developing diagnostic services with Fusion’s concept-to-production model works to continue the focus of driving the development of diagnostic and medical technology services for regulatory and commercial use. Financial terms of the deal were not disclosed.
Fusion Biotec is a contract engineering and manufacturing firm in southern California dedicated to the diagnostics and medical device industry. Fusion Biotec is ISO 13485 certified for development and manufacturing, FDA and FDB registered.
Founded in 2021, Veranex is a comprehensive, global, tech-enabled service provider dedicated to the MedTech industry.
According to the LevinPro HC database, this represents the 37th acquisition in the contract development manufacturing organization subsector of 2022. This also marks Veranex’s second transaction of the quarter. The company announced its acquisition of Devicia on October 11, 2022.
